Dube Michael P 4
4 · Intellia Therapeutics, Inc. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-10-02$19.01/sh−2,012$38,248→ 47,012 total
Footnotes (2)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2024, and does not represent a volitional trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.01, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 2, 2024 at each separate price.